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Substrate-induced conformational dynamics
of the dopamine transporter
Anne Kathrine Nielsen 1,2, Ingvar R. Möller 1,2, Yong Wang 3, Søren G.F. Rasmussen4,
Kresten Lindorff-Larsen 3, Kasper D. Rand 2 & Claus J. Loland 1
The dopamine transporter is a member of the neurotransmitter:sodium symporters (NSSs),
which are responsible for termination of neurotransmission through Na+-driven reuptake of
neurotransmitter from the extracellular space. Experimental evidence elucidating the coor-
dinated conformational rearrangements related to the transport mechanism has so far been
limited. Here we probe the global Na+- and dopamine-induced conformational dynamics of
the wild-type Drosophila melanogaster dopamine transporter using hydrogen-deuterium
exchange mass spectrometry. We identify Na+- and dopamine-induced changes in speciﬁc
regions of the transporter, suggesting their involvement in protein conformational transitions.
Furthermore, we detect ligand-dependent slow cooperative ﬂuctuations of helical stretches in
several domains of the transporter, which could be a molecular mechanism that assists in the
transporter function. Our results provide a framework for understanding the molecular
mechanism underlying the function of NSSs by revealing detailed insight into the state-
dependent conformational changes associated with the alternating access model of the
dopamine transporter.
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Dopaminergic neurons control a broad array of basic psy-chological functions such as mood, motivation, reward,and addiction1. A major component in dopamine (DA)
signaling homeostasis is the dopamine transporter (DAT)2, which
is responsible for terminating dopaminergic neurotransmission
by rapid reuptake of DA. The central role of DAT in this process
is substantiated by the fact that DAT malfunction is associated
with a range of neurological diseases including early onset par-
kinsonism3 and ADHD4. This makes DAT a major target for
therapeutic drugs5. Furthermore, the rewarding and addictive
effects of illicit drugs, such as cocaine and amphetamines, are also
due to their inhibition of DAT function6.
DAT belongs to the family of Neurotransmitter:Sodium Sym-
porters (NSSs) together with transporters for serotonin (SERT)
and norepinephrine (NET)7. NSSs are secondary active trans-
porters that harness the energy stored in the Na+ gradient to
drive the uphill transport of their substrate across the cell
membrane. X-ray structures of several NSS members across
kingdoms have revealed highly similar structures8–11, suggesting
a preserved transport mechanism—even for transporters outside
the NSS family12.
Crystal structures of DAT from Drosophila melanogaster
(dDAT), reveal a protein with 12 transmembrane domains (TMs)
—with the ﬁrst 10 TMs organized in an inverted symmetry
between the ﬁrst- and subsequent ﬁve TMs10,13,14, also known as
the LeuT-fold8. The binding site for substrate and ions are
organized in the center of the protein through interactions with
backbone and side chain residues in regions of TM 1, 3, 6, and 8.
Notably, all current X-ray structures of eukaryotic NSS
proteins10,11,13–15 possess an outward-open conformation, which
largely precludes interpretations on transporter function.
NSS proteins are believed to follow an alternating access
transport mechanism16,17 suggesting that the central binding site
is alternatingly accessible to the intracellular and the extracellular
side of the membrane. This requires the existence of external and
internal ‘gates’, i.e., dynamic structural units that are capable of
occluding access to the substrate binding site from the external-
or internal environment, respectively. Crystal structures of bac-
terial homologs have been solved in multiple conformations,
including outward-open9, outward-occluded8, and inward-open9.
This allows for interpretations about transitions between the
states. It has been speculated that alternating access is ensured
through a rocking-bundle mechanism18,19, where a core domain
of TM 1, 2, 6, and 7 moves relative to a scaffold domain of TM 3,
4, 8, and 9. TMs 5 and 10 are linkers between the domains.
Most inferences on protein dynamics in NSS proteins have
been derived from experiments on bacterial family
members8,9,20–27. To gain speciﬁc insight into the molecular
function of the more clinically relevant mammalian NSS proteins,
a detailed understanding of the protein dynamics involved in the
allosteric coupling between substrate- and Na+-binding, and the
control of the gating mechanisms, is essential.
Here we investigate how ion and substrate binding modulate
the conformational dynamics of wild-type dDAT using
hydrogen-deuterium exchange mass spectrometry (HDX-MS).
Our results provide direct experimental insights into the con-
formational dynamics underlying substrate binding and iso-
merization between functional states of DAT. The results indicate
that the alternating access mechanism in dDAT largely follows
the rocking-bundle model with movements in the core domain
relative to the scaffold domain. In addition, we ﬁnd that several
helical regions of dDAT undergo slow cooperative ﬂuctuations
that break multiple backbone hydrogen bonds resulting in an
open and exchange-competent conformation, which refolds or
closes at a rate that is signiﬁcantly slower than the chemical
exchange rate. These slow concerted ﬂuctuations of helices are
modulated by ligand binding, suggesting them to be an intrinsic
part of the transport mechanism.
Results
MD simulations reveal structural stability of dDAT. Despite the
increasing attention to the role of the lipid bilayer in modulating
NSS transport activity and function28–32, studies of the structure
and function of DAT is still generally limited to detergent
micelles10,13,14. To address the possible risk of perturbing the
structure and dynamics of DAT by the use of detergent micelles
as membrane mimic, we carried out a comparison of all-atom
MD simulations of dDAT embedded in a n-dodecyl β-D-
maltoside (DDM) micelle and in a mixed lipid bilayer consist-
ing of phosphatidylcholine (POPC), phosphatidylethanolamine
(POPE), phosphatidylglycerol (POPG), and cholesterol (CHOL)
in a 3:1:1:1 ratio. As existing structures of dDAT10,13,14 contain
truncations, deletions, and mutations, we ﬁrst constructed a
model of the wild-type protein using the outward-facing open
crystal structure13 (PDB ID: 4XP1) with two Na+ ions, one Cl−
ion and DA bound in the central binding pocket, and modeled
the deleted part of the extracellular loop 2 (EL2) and corrected the
mutations. We retained the crystallographically-resolved choles-
terol molecule bordered between TM 1a, 5, and 7 as well as a
cholesteryl hemisuccinate molecule (CHS; which we replaced by
cholesterol) at the interface between TM 2, 7, and 11, which have
been suggested to be important for transporter activity13,32. We
performed two sets of 500 ns explicit-solvent all-atom MD
simulations starting from our model of dDAT in a DDM micelle
and in a POPC/POPE/POPG/CHOL bilayer (Fig. 1a). We found
that the two Na+ ions, the Cl− ion, DA and the cholesterol
molecules were stable in their binding sites in the 500 ns MD
simulations. Importantly, the root-mean-square deviations
(RMSD) of the dDAT model from the starting dDAT crystal
structure were below 0.25 nm (Fig. 1a) suggesting that the Na+-
and DA-bound state of dDAT in complex with cholesterol is
stable in both the DDM micelle and the lipid bilayer. Moreover,
the root-mean-square ﬂuctuations (RMSF) of dDAT in the DDM
micelle and the lipid bilayer were similar (Fig. 1b, c), indicating
that the two systems display comparable structural dynamics in
the simulations. The regions displaying the lowest RMSF are
mainly located at the TM domains, while loop regions on the
intracellular and extracellular sides show higher RMSF values.
Importantly, the ﬂuctuations for the two system setups are overall
comparable. This suggests that dDAT embedded in a DDM
micelle displays similar dynamics as in a POPC/POPE/POPG
lipid bilayer indicating that the micelles are suitable membrane
mimics for studies of the conformational dynamics of dDAT,
where solubilization from the lipid cell membrane is a require-
ment. These results also conﬁrm previous HDX-MS performed
on the Xylose transporter33 and the hydrophobic amino acid
transporter LeuT27 in DDMmicelles and in nanodiscs, which also
reported only minor differences in the conformational dynamics
between the two settings. Taken together, although there are
subtle differences in the structural stability between the MD
simulations of dDAT in DDM micelles and a lipid bilayer, we ﬁnd
that our preparation of dDAT in DDM micelles as performed
below, is a useful model system for probing dDAT conforma-
tional dynamics.
Characterization of puriﬁed dDAT. To investigate the con-
formational dynamics of DAT during ion and substrate binding,
we expressed the wild-type dDAT in suspension HEK293 cells
(Expi293F) using the BacMam expression system34,35. The
transporter was puriﬁed by immobilized-metal afﬁnity chroma-
tography similarly to the procedure ﬁrst described for the dDAT
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crystallization constructs10,13,14 in the presence of Na+ in a buffer
containing mixed micelles consisting of DDM, CHS, and lipids
(POPC, POPE, and POPG). The presence of the cholesterol
analog CHS and lipids in combination with DDM in the buffer
increases the resemblance of the membrane mimic to a lipid
bilayer and proved essential to preserve dDAT functionality
throughout the puriﬁcation procedure in agreement with pre-
vious reports10,13. The purity and activity of the puriﬁed
transporter were evaluated by SDS-PAGE analysis and scintilla-
tion proximity assay (Supplementary Fig. 1). For subsequent
binding and HDX-MS experiments, the transporter was left gly-
cosylated to avoid possible deviation from its native conforma-
tional properties. Puriﬁed dDAT bound the high-afﬁnity inhibitor
[3H]nisoxetine with a dissociation constant (Kd) of 80 ± 6 nM
(mean ± s.e.m., n= 3) in the presence of 200 mM NaCl. Based on
the concentration of dDAT determined from SDS-PAGE analysis,
the maximum number of binding sites (Bmax) determined from
[3H]nisoxetine saturation binding suggested that >95% of dDAT
had preserved binding capability after detergent solubilization.
Displacement of [3H]nisoxetine by DA yielded an inhibition
constant (Ki) of 1.7 ± 0.2 µM (mean ± s.e.m., n= 3). This is in
agreement with the afﬁnity of DA previously reported for
wild-type dDAT expressed in transfected mammalian cells13,36
indicating that a native functional conformation of the trans-
porter is conserved in DDM/CHS/lipid mixed micelles.
Dopamine transport intermediates. To dissect the conforma-
tional dynamics of dDAT during DA transport, we studied
intermediate states proposed by the alternating access model in
solution using HDX-MS. The exchange rates of backbone amide
hydrogens in a protein are sensitive reporters of the presence and
relative stability of hydrogen bonds37. Hydrogens participating in
bonding networks to form regions of higher-order structure, such
as α-helices and β-sheets, will exchange according to the pro-
pensity of these hydrogen bonds to break as a result of dynamic
protein motions. Accordingly, the exchange is correlated with
conformational stability or ﬂexibility of the protein. Thereby,
HDX-MS also provides a means of measuring conﬁned local
changes in protein structure and dynamics, e.g., as a function of
ion or ligand binding, within the entire protein27,38–40.
In the absence of Na+ and DA (apo state), we expect dDAT to
ﬂuctuate between multiple conformational intermediates in a
dynamic equilibrium as has been observed for bacterial
homologs22,41. Binding of ions and ligands will shift this
equilibrium to favor distinct conformational states. Based on
structural dynamics of bacterial homologs22,41 using pairs of spin
labels, we expect dDAT to be biased toward an outward-open
conformation in the presence of Na+, while the presence of Na+
and DA combined would shift the equilibrium of sampled
conformations towards an occluded and an inward-open state.
Here we examined the HDX behavior of dDAT in an apo state, a
Na+-bound state and a Na+- and DA-bound state from peptides
covering 77.2% of the transporter (Fig. 2a; Supplementary Fig. 2a).
Notably, only peptides showing signals with appropriate signal-
to-noise ratio across all sampled states (Supplementary Fig. 2b)
and time points (i.e., 0.25–480min) were included in the HDX
analysis (Supplementary Table 1, 2).
Comparing the HDX between the three states provided a direct
spatially-resolved view of regions important for ion and substrate
binding and for changes in isomerization between dDAT
conformational states. The majority of identiﬁed dDAT peptides
showed a gradual increase in deuterium uptake as a function of
time indicating the presence of secondary structured regions,
while the N- and C-termini as well as major parts of EL2
displayed maximum uptake after the ﬁrst sampled time point (15
s) suggesting unstructured regions, which is in good agreement
with the structural fold observed in the crystal structures10,13,14
(Fig. 2b; Supplementary Fig. 3). Examples of deuterium uptake in
speciﬁc DAT regions are shown in Fig. 2b. A large portion of the
identiﬁed peptides showed changes in HDX upon ligand binding.
The changes were mostly towards less deuterium uptake (see
TM1a, TM6a, and TM8–9 in Fig. 2b) indicating a stabilizing
effect, but increased uptake were also observed (see TM1b region
in Fig. 2b). Other regions, on both the extra- and intracellular
sides, showed no change in HDX upon ligand binding as seen for
TM8 and the C-terminal region (Fig. 2b). The latter region is
likely unstructured as it displayed maximum uptake after the ﬁrst
sampled time point.
0
0.1
0.2
a
b
c
0 100 200 300 400 500
R
M
SD
 (n
m)
 to
 4X
P1
MD Time (ns)
0.
25
 n
m
0
R
M
SF
dDAT in POPC/POPE/POPG/CHOL Bilayer
dDAT in DDM Micelle
Fig. 1 MD simulations of dDAT embedded in a detergent micelle and a lipid
bilayer. a Trajectories of the root-mean-square deviation (RMSD) of the
dDAT model to the dDAT crystal structure (PDB ID: 4XP1) when
embedded in a DDM micelle (green) and in a POPC/POPE/POPG/CHOL
bilayer (blue). b, c Structural ﬂuctuations of dDAT in a DDM micelle (b)
and a POPC/POPE/POPG/CHOL bilayer (c) are illustrated by projecting
the corresponding root-mean-square ﬂuctuation (RMSF) proﬁles onto the
last frame of the MD trajectory of dDAT in the mixed bilayer. The thickness
of the tube represents the amplitude of the ﬂuctuations. To provide a better
visualization, the thickness is scaled by the RMSF values in the region from
0 to 0.25 nm (the residues with RMSF > 0.25 nm are considered as the
same as RMSF= 0.25 nm). The DDM micelle and the lipid bilayer used in
the MD simulations are shown as background
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Na+-induced conformational dynamics. To investigate the
changes in conformational dynamics upon Na+ binding, we
compared the deuterium uptake over time between the apo
state and the Na+-bound state by calculating the difference in
uptake for each individual dDAT peptide at all ﬁve sampled time
points (Fig. 3a). Transition from the apo state to the ion-bound
proposed outward-open state was predominantly characterized
by a decrease in HDX corresponding to a decrease in dynamics
and stabilization of H-bonding of regions both at the extracellular
and intracellular side of dDAT (Fig. 3b, c). The effects were
mainly focused around the bundle domain (i.e., TM1, 2, 6, and 7).
Also, loop regions connecting the bundle domain were involved
(i.e., EL1, EL3, EL4, and IL3). However, effects were also seen in
the scaffold domain, where Na+-induced stabilization was
observed in the extracellular part of TM10 (residue 470–480) and
the intracellular ends of TM8 and 9 connected by IL4 (residue
429–451). Also, a minor part of EL2 (residue 215–222), IL5
(residue 495–503) and the entire TM12 including the C-helix
(residue 551–567, 569–594) showed signiﬁcant stabilization upon
Na+ addition (Fig. 3).
Speciﬁcally, we observed reduced HDX of TM1a and the
connected residues of the N-terminal end (residue 28–43), TM6b,
IL3 and the intracellular part of TM7 (residue 320–328, 330–347).
These regions have all been proposed to participate in the
opening and closing of the intracellular vestibule9,22,24,42, and the
observed stabilization suggests isomerization of the inner-gate to
a closed conformation as expected upon Na+-binding43,44. On
the extracellular side, we observed increased HDX in the hinge
region and TM1b (residue 45–56) together with large parts of
TM7 (residue 349–357) and EL4 (residue 366–380) including the
ﬁrst helix of the loop (EL4a), while TM6a (residue 303–318) and
TM2 (residue 58–73) showed decreased HDX upon ion binding.
The domains of TM7 and EL4a have been associated with
isomerization to the outward-open conformation22, supporting
the observations above on the intracellular side. Residues in the
other domains are involved in the coordination of the two Na+
and the Cl− in the crystal structures of dDAT10,13,14. Interest-
ingly, the destabilizing and stabilizing effects seen in the bundle
domain do not correlate with our observations from LeuT27,
where Na+ stabilized the intracellular parts and destabilized the
extracellular regions. Here, stabilization and destabilization do
not show a clear pattern: the extracellular parts of TM1 and TM7
are destabilized, but stabilized in TM2 and TM6. A different
pattern is seen on the intracellular side, where TM1 and TM6 are
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Fig. 2 HDX of local regions of dDAT in different functional states. a Cylindrical representation of the crystal structure of dDAT in complex with two Na+
ions (blue spheres), one Cl− ion (red sphere) and DA (orange spheres) (PDB ID: 4XP1). To obtain information about HDX of local regions of dDAT, we
digested the transporter enzymatically and identiﬁed the generated peptides using MS. Regions of dDAT covered by identiﬁed peptides are highlighted in
cyan. Wild-type dDAT was used for the HDX-MS experiments, however, the crystal structure shown has truncated N- and C-termini and deleted part of
EL2. The C-terminal His-tag used for puriﬁcation of the wild-type dDAT is added to the structure as circles with one-letter codes. b Deuterium uptake is
plotted as a function of labeling time (i.e., 0.25–480min) for representative peptides of dDAT. Red, blue, and orange curves illustrate the deuterium uptake
for dDAT in the apo, Na+-bound, and Na++DA-bound state, respectively. Values represent means of three (apo and Na++DA) or six (Na+)
independent measurements. Standard deviations are plotted as error bars but are in most instances too small to be visible. Maximum-labeled control
samples are shown as black circles at 1440min. Insets: The location of the corresponding peptide is highlighted in black on the topology map of dDAT.
Source data are provided as a Source Data ﬁle
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stabilized, TM7 destabilized and no effect in TM2. The
asymmetric conformational dynamics indicate that the bundle
domain does not necessarily operate as a rigid bundle as
suggested for LeuT18,19, but rather mediate the transitions in
the TM-domains that facilitate substrate binding and subsequent
translocation. Within EL4 we also observed both destabilizing
(EL4a, residue 366–380) and stabilizing (residue 381–390
including the second helix of EL4 (EL4b)) effects of ion binding.
EL4 in LeuT exhibited a similar HDX proﬁle between the
outward-favoring condition and an inward-favoring mutant23.
Together, this suggests that, as in LeuT, Na+ binding favors
the outward-open conformation of dDAT, with TM7 and
EL4 participating in the opening of the extracellular vestibule.
Na+ - dependent decrease in HDX was especially pronounced in
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Fig. 3 Effect on local HDX upon ion binding to dDAT. a Chart showing differences in the average deuterium uptake (ΔHDX) between the apo state and the
Na+-bound state for the 85 identiﬁed peptides at the ﬁve sampled time points (orange—0.25min; red—1 min; cyan—10 min; blue—1 h; black—8 h). The
individual dDAT peptides are arranged along the x-axis starting from the N-terminal and ending on the C-terminal. The peptide number refers to
Supplementary Table 2. Positive and negative values indicate reduced and increased HDX, respectively, upon binding of Na+. Values represent means of
either three (apo state) or six (Na+ state) independent measurements. Structural motifs in dDAT are marked along the x-axis together with regions
showing correlated exchange kinetics (EX1) in at least one of the two states. The dotted lines (±0.26 D) mark a threshold value for signiﬁcant differences in
HDX corresponding to the 95% conﬁdence interval, calculated from the pooled standard deviations for all time points. b, c Regions showing signiﬁcant
differences (Student’s t-test p-value < 0.01) in deuterium uptake between the apo state and the Na+-bound state for at least two consecutive time points
are mapped onto the crystal structure (b) (PDB ID: 4XP1) and snake diagram (c) of dDAT. Regions are colored red and blue to indicate dDAT segments
becoming destabilized (increased HDX) or stabilized (decreased HDX), respectively, upon binding of Na+. Regions colored light grey displayed unchanged
HDX while regions in dark gray were uncovered by peptide sequences. Wild-type dDAT regions including part of EL2 (residue 162–202) and the N- and C-
termini (residue 1–24 and 601–645, respectively) are only marked on the snake diagram in c as they were not resolved in the crystal structure (b) or were
truncated in the construct used for crystallization. Source data are provided as a Source Data ﬁle
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the helical parts of EL2, and to a lesser extent in EL3 as well as in
the extracellular part of TM10 (residue 470–480). This part of
TM10 has Asp475 at its center, which likely closes access to the
substrate binding site through a salt bridge to Arg52 in TM1b8,45.
We see that Na+ addition stabilizes the backbone interactions of
the TM10 domain while destabilizing the H-bonding interactions
of the TM1b backbone. Interestingly, the most noteworthy
reduction in HDX upon Na+ binding to dDAT was detected in
TM8-IL4-TM9 (residue 429–451) suggesting a yet undeﬁned role
of this region in dDAT function.
TM3 (residue 112–132) and TM8 (residue 405–428) in the
scaffold domain, which lines the central binding site and form
interactions with ions in the crystal structures, did not show ion-
induced changes in HDX. In addition, the intracellular part of
TM5 (peptide 246–269) showed no change in conformational
dynamics between the apo state and the Na+-bound state
indicating that dDAT under these conditions does not visit an
inward-open conformation, where the intracellular part of TM5
changes the conformational dynamics. This is in contrast to what
we observed for LeuT27, and thus indicates a potentially
important difference in the isomerization pattern between the
bacterial homologs and the eukaryotic dDAT.
Dopamine-induced conformational dynamics. To examine the
conformational dynamics associated with substrate binding, we
compared the HDX-MS proﬁle of the Na++DA-bound state to
the Na+-bound state (Fig. 4a). Overall, the observed differences
are in the same regions as the differences between the apo state
and the Na+ - bound state (Supplementary Fig. 4), though not as
pronounced.
Regions around the dopamine binding site in TM1 (residue
38–43, 45–56) and TM6 (residue 304–318, 326–328) revealed
decreased dynamics, demonstrating a stabilization upon substrate
binding (Fig. 4b, c). Notably, the regions involved in the
extracellular salt bridge (TM1b (residue 45–56) and the
extracellular part of TM10 (residue 470–480)) were stabilized
further. The crystal structure of dDAT in complex with DA has
conﬁrmed several interactions between DA and residues in TM3
and TM88; however, we do not observe altered dynamics in these
helical segments. A reduction in deuterium uptake was observed
for IL3, IL4, as well as for the intracellular parts of TM7, TM8,
and TM9 (residue 330–347, 429–451). Thus, the Na+-induced
stabilization of intracellular regions involved in gate-closing was
enhanced by binding of DA. The binding of DA also slightly
stabilized the extracellular part of TM12 (TM12a, residue
556–567). The role of TM12 in eukaryotic NSSs is unclear;
however, in the crystal structure of the human SERT, a CHS
molecule was found to bind near TM12a11, although this was not
seen in the structures of dDAT.
DA did also induce destabilization in certain regions, particularly
in the tip of EL4 and EL4b (residue 381–390) and the middle part of
TM7 (residue 349–357) (Fig. 4). Effects were also seen in the N-
terminal region connected to the beginning of TM1 (residue 28–37)
and the extracellular part of TM2 (residue 58–65). Both TM1a and
EL4 in LeuT have shown to be involved in transitioning to the
inward facing state27,46. Changes in the intracellular part of TM7
have also been reported for leucine binding to LeuT, but there it
caused a stabilizing effect27. The intracellular part of TM7 is part of
the bundle domain. A destabilizing effect could indicate a
transitioning towards an inward facing state.
Taken together, we ﬁnd that the conformational dynamics
associated with Na+ and DA binding correlate with the rocking-
bundle hypothesis illustrated with pronounced effects in TM1–2,
6–7 of the bundle domain relative to minor effects in TM3–5,
8–10 of the scaffold domain.
Cooperative ﬂuctuations in dDAT helical domains. In an HDX-
MS experiment, the exchange between hydrogens and deuteriums
most commonly occurs through an EX2 time regime in which the
exchanging protein segment undergoes opening and closing
dynamics that occur at rates (kop and kcl) that are signiﬁcantly
faster than the rate of the chemical exchange reaction kch (spe-
ciﬁcally, kcl » kch)40,47. Thus, the exchange of individual backbone
amide hydrogens in this segment is uncorrelated and the
observed rate of HDX (kHDX) reports on the stability of local
hydrogen-bonded structure in this segment. Such uncorrelated
exchange appears as a gradually increasing binomially distributed
isotopic envelope in the mass spectrum (see Supplementary
Fig. 5a for example). While the majority of proteins exchange
with EX2 kinetics under physiological conditions, there are
increasing numbers of membrane proteins with reported EX1
kinetics27,48,49. In contrast to EX2 kinetics, EX1 kinetics is
characterized by concerted opening and closing motions of sev-
eral backbone amide hydrogen bonds that are slower than the rate
of the chemical exchange (speciﬁcally, kcl « kch). In the mass
spectra, this is seen as a bimodal isotopic pattern resulting from
the presence of a low-mass population, which has not yet
undergone the cooperative ﬂuctuating motion required for
exchange, and a high-mass population in which the concerted
opening event has occurred and multiple hydrogens have
simultaneously exchanged for deuterium (Fig. 5, Supplementary
Fig. 5b, 6). In the EX1 time regime, the observed rate of HDX is
equal to the rate of the concerted opening (kHDX= kop)40,47,50.
Thus, the presence of EX1 kinetics in a segment of a protein (e.g.,
a TM helix) allows a direct measure of the rate of conformational
opening and the half-life of the closed/folded state (t1/2). The low-
and high-mass populations can be more or less separated on the
m/z axis depending on the number of involved backbone amide
hydrogens, and the two populations might overlap due to the
presence of EX2 and EX1 kinetics in the same peptide (EXX
kinetics).
We detected EX1 and EXX kinetics in EL2 (residue 216–222),
TM6b-IL3-TM7 (residue 330–347), the middle part of TM7
(residue 349–357), parts of TM12a (residue 562–567), TM12b
(residue 569–577) as well as the helical part of the C-terminal
(residue 578–594) in at least one of the investigated states (Fig. 5,
Supplementary Fig. 5b, 6). Furthermore, signs of EX1/EXX
kinetics were observed in TM8-IL4-TM9 (residue 429–451) and
the extracellular part of TM10 (residue 470–480); however, a
reliable quantitative bimodal deconvolution was not possible for
peptides spanning these regions (referred to as ‘potential EX1/
EXX kinetics (uncharacterized)’ in Fig. 5). Interestingly, the
transition from the low-mass population to the high-mass
population was state-dependent, meaning that the opening rate
(kop) was modulated by Na+ and DA binding, as seen for peptide
329–346 from the TM6b-IL3-TM7 region (Fig. 5c). Importantly,
the existence of the EX1 exchange pattern was conﬁrmed by being
present in all replicates as well as overlapping peptides in all cases
(Supplementary Fig. 5b). For some of the peptides, it was possible
to obtain a quantitative measure for the rate of the conforma-
tional transition (kop). For these peptides, we estimated the kop
and thus the half-life of the closed (folded) state (t1/2) by
quantitating the time-resolved depletion of the low-mass
population (Fig. 5d, Table 1). In general, kop for the regions
showing correlated exchange was decreased upon Na+ binding,
and in some cases even further by the binding of DA (Table 1).
The opening rate between different regions differed remarkably
(from <0.001 s−1 for peptide 577–593 to 0.02 s−1 for peptide
329–347 in the apo state). For some regions the bimodal
distribution ﬁt was affected by the two populations not being
sufﬁciently separated on the m/z axis due to the presence of EXX.
Such regions were not analyzed further for their rate of opening
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(Table 1). Importantly, the difference between the high- and low-
mass populations allowed us to estimate the number of amides
participating in the ﬂuctuation events (Table 1). These numbers
reveal cooperative ﬂuctuation of helical stretches spanning several
residues. For peptide 215–222 covering the helical regions of EL2,
the difference between the two populations corresponds to
exchange of 4–5 backbone amide hydrogens, which reﬂects
cooperative ﬂuctuation of more than one helical turn, while the
difference seen for the TM6b-IL3-TM7 region corresponds to the
exchange of 6–7 backbone amide hydrogens or involvement of
1.7–1.9 helical turns. The cooperative ﬂuctuations in helical
structures in dDAT reveal relatively slow local motion events.
Notably, we did not sample longer time intervals than 480 min as
we have evidence that the stability of the dDAT apo state at 25 °C
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would interfere with the analysis (Supplementary Fig. 7). For
some regions showing correlated exchange kinetics, this did not
allow a complete transition to the high-mass population, and thus
kinetic parameters could not be extracted for these regions
(TM12 and the middle part of TM7). Hereof, the stretches in
TM12 (residue 561–567 and 569–576) showed very slow EX1
kinetics in the apo state, while ion and substrate resulted in
almost no exchange in the sampled time intervals. The middle
part of TM7 (residue 349–357) also showed slow correlated
exchange in the apo state, while the Na+ and Na+- and DA-
bound states did not show EX1/EXX kinetics within the sampled
time points. Finally, the C-helix (residue 578–594) showed
correlated exchange for the apo state (Table 1) as well as the Na+-
bound and Na+- and DA-bound states, however, extraction of
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kinetic parameters was not possible for the two latter states due to
spectral complication by the presence of EXX kinetics (Supple-
mentary Fig. 6f). Nevertheless, it was clear that the opening rate
was reduced by the presence of ion and substrate. Notably, we did
not observe any bimodal distributed isotopic pattern in any of the
sampled states for peptides covering TM1b, EL4 or the
intracellular part of TM5 as previously observed for LeuT23,
suggesting differences in the mode of transition between the two.
However, it is also possible that the differences are, at least in
part, a consequence of sample conditions. To ensure sample
stability of dDAT during the 8 h time-frame of the HDX-MS
experiment, we performed analytical size-exclusion chromato-
graphy (SEC) of the apo state and the Na+-bound state after
incubation at 25 °C in similar buffers as for the HDX experiments
and matching time intervals (Supplementary Fig. 7). Analytical
SEC showed that dDAT in Na+ is very stable and remains
monomeric showing no formation of multimers over the 8 h
period. We did observe that dDAT slowly formed multimers
exclusively in the apo state with ~30% decrease in the monomeric
peak after 8 h and concomitant increase in the oligomeric/void
volume fraction. Importantly, our results do not indicate that the
EX1 kinetics observed in both the apo, Na+-bound, and Na++
DA-bound states are related to the multimerization observed for
the apo state. First, the Na+-bound state of dDAT remains fully
monomeric during the HDX-MS time-frame, yet we observe EX1
kinetics in both this and the Na++DA-bound state. Second, the
EX1 kinetics observed in all regions of dDAT (apart from TM12)
are much faster than the rate of multimerization observed by
SEC, i.e., we have ~100% of interconversion to the high-mass
fraction signiﬁcantly before 8 h, e.g., TM6b-IL3-TM7 fully
converts within 10 min in the apo state and most other regions
even faster (Fig. 5, Table 1). Third, the EX1 kinetic behavior in
TM12 shows ~30% of the high-mass population after 8 h
(Supplementary Fig. 6d, e), which could in principle correlate
with the increased amount of multimerized dDAT. However, any
precipitated dDAT resulting from multimerization would be
removed during the ﬁltration step before online pepsin cleavage
and MS analysis. Furthermore, in order for irreversible multi-
merization to disguise itself as EX1 kinetics in TM12, it would
then need to be due to a local irreversible unfolding of TM12 in a
population of the protein over time. The remaining monomeric
population would however likely exchange according to EX2. The
low-mass population in TM12 does not detectably shift along the
m/z axis within the entire 8-h period, thus indicating that
exchange observed in TM12 occurs exclusively via an EX1
mechanism.
Discussion
Structural studies of NSS proteins have mainly focused on bac-
terial homologs such as LeuT and MhsT for which several crystal
structures in different conformational states have been
solved8,9,25. These structures have contributed with indispensable
knowledge about the mechanism of action for this class of
transport proteins. The addition of structures of dDAT10 and
hSERT11 in a substrate- or inhibitor-bound outward-facing state
has further advanced the studies to cover the eukaryotic trans-
porters, which overall showed the same structural fold. However,
the constructs used for the eukaryotic NSS proteins contained
major truncations, deletions, and mutations that rendered most
of them inactive in substrate transport. Furthermore, the infor-
mation gained from crystal structures of eukaryotic NSS proteins
needs further complementation by studies that capture the
motions of the proteins in order to fully understand the
Table 1 Kinetic parameters for dDAT regions showing EX1 or EXX kinetics
Peptide State R2 kop (s−1) t1/2 (min) #NHs
EL2 (215–222) Apo 0.86 0.016
[0.011; 0.024]
0.73
[0.49; 1.10]
4–5
Na+ 0.99 0.0001
[0.0001; 0.0013]
103.40
[89.11; 122.20]
Na++DA 0.96 0.0002
[0.0001; 0.0003]
56.86
[40.75; 80.91]
TM6b-7 (329–346) Apo 0.95 0.01
[0.01; 0.02]
0.89
[0.69; 1.17]
5–6
Na+ 0.98 0.0019
[0.0016; 0.0022]
6.09
[5.22; 7.06]
Na++DA 0.97 0.0005
[0.0004; 0.0007]
21.14
[15.77; 27.86]
TM6b-7 (329–347) Apo 0.81 0.02
[0.01; 0.03]
0.65
[0.40; 1.02]
6–7
Na+ 0.99 0.002
[0.001; 0.002]
7.12
[6.22; 8.15]
Na++DA 0.99 0.0006
[0.0005; 0.0008]
18.04
[14.42; 22.38]
TM7 (348–357) N.D.
TM8–9 (429–451) N.D.
TM10 (469–480) N.D.
TM12 (561–567) N.D.
TM12 (569–576) N.D.
C-helix (577–593) Apo 0.70 0.001
[0.0004; 0.0024]
11.40
[4.77; 28.49]
5–6
Na+ N.D.
Na++DA N.D.
The rate constant of opening (kop) and the half-life of the low-mass population/folded state (t1/2) were extracted from ﬁtting the average relative abundance of the low-mass population as a function of
labeling time to an exponential decay function for each state. (n= 3 for all time points for the apo state and the Na+-and DA-bound state, n= 6 for all time points for the Na+-bound state). Values
deﬁning the 95% conﬁdence interval are given in square brackets. The coefﬁcient of determination (R2) is given to indicate the goodness of the ﬁt. Furthermore, the number of amides (#NHs)
participating in the cooperative ﬂuctuation event was calculated as the difference in HDX between the high- and low-mass populations corrected for back-exchange. N.D. indicates peptides for which kop
and t1/2 could not be determined from the mass spectra (Supplementary Fig. 6). Source data are provided as a Source Data ﬁle
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conformational rearrangements leading to substrate transport. So
far, such studies include electron paramagnetic resonance (EPR)
spectroscopy22,44 and FRET-based strategies20,21,51–53, which also
require protein modiﬁcations and has so far only been applied to
the bacterial homologues. Recent studies of LeuT23,27 and SERT54
have demonstrated the application of HDX-MS to assess the
conformational dynamics of wild-type NSS proteins.
Here we intended to advance studies of the conformational
dynamics of NSS proteins from the bacterial homologs to the
eukaryotic dDAT in order to broaden the understanding of
structural elements involved in the transport mechanism of DA.
HDX-MS allowed us to obtain detailed insight into the con-
formational dynamics associated with both Na+ and DA binding
by identifying regions that changes stability and/or conformation
upon ligand binding and, accordingly, must be implicated in the
transport of substrate.
Our ﬁndings show that changes in conformational dynamics
induced by ion and substrate binding mainly are located around
the bundle domain (TM 1–2, 6–7), while the scaffold domain
(TM 3–5, 8–10) overall remains unchanged with stabilization
only localized to the extracellular part of TM10 and the end of
helices continuing to loop regions (e.g., TM8-IL4-TM9). This is
consistent with the rocking-bundle model for the alternating
access transport mechanism, which predicts that isomerization
from the outward-open to the inward-open conformation hap-
pens through a rotation of the bundle domain relative to the
scaffold domain around an axis through the central substrate
binding site18,19. However, the DA-induced increased dynamics
in some parts of the bundle domain, in particular the middle part
of TM7, indicates that the bundle domain moves as a more
complex dynamic multi-jointed bundle rather than a rigid body.
This is supported by studies of LeuT8,9,22. We also ﬁnd that the
addition of Na+ results in the stabilization of regions forming the
intracellular gate, such as regions including Arg27 in TM1,
Tyr334 in IL3 and Asp435 in the intracellular part of TM8.
Together with the destabilization of TM1b, TM7 and part of EL4
at the extracellular side, this is in agreement with the formation of
an inward-closed/outward-open conformation of dDAT. The
DA-induced decrease in dynamics of TM1b and TM6a, together
with further stabilization of loop regions at the intracellular side
(IL3, IL4), indicate stabilization of the extracellular as well as the
intracellular gate, which would be expected in the transition to an
outward-facing occluded conformation. Concurrent destabiliza-
tion of the middle part of TM7, the hinge region and b-helix of
EL4, part of the N-terminus and beginning of TM1a, suggests the
importance of these regions in pushing dDAT towards an inward
opening. Interestingly, the biggest effects of both ion and sub-
strate binding were seen in the TM8-IL4-TM9 region. The loop
region was highly dynamic in the apo state, but was stabilized in
the presence of Na+ and even further by DA. To our knowledge,
this region has not been reported to be mechanistically important
in structural studies of bacterial homologs. However, studies of
the GABA transporter (GAT1) have demonstrated the role of IL4
as a regulatory barrier for substrate transport55,56. Furthermore,
recent molecular dynamics simulations of homology modeled
human DAT (hDAT) have reported the possible role of IL4 in
triggering the inward opening and release of Na+ through lipid
mediated interaction with the N-terminal region57,58. Our recent
HDX-MS data of LeuT importantly did not report any ion- or
substrate-induced changes in the TM8-IL4-TM9 region27.
Instead, we reported slow cooperative ﬂuctuations (EX1) in the
intracellular part of TM5, supporting the helical unwinding
movement seen for this region in the crystal structure of MhsT25,
suggested to be required for Na+ release. Our data on dDAT do
not show the same slow cooperative ﬂuctuations in this region,
suggesting differences in the mode of transition, between the
eukaryotic dDAT and its prokaryotic cousins. While the tem-
perature and pH was similar, we cannot rule out that sample
preparation requirements for LeuT and dDAT could contribute
to this observed difference. Indeed, the presence of lipids and
CHS were absolutely essential for dDAT functionality and they
will most likely contribute to the conformational dynamics of
dDAT, possibly bringing it closer to its physiological state in a
lipid bilayer. Clearly, the added lipids are coordinated at parts of
dDAT that cannot be replaced by DDM in much the same way as
cholesterol has its unique binding sites10. Nevertheless, coop-
erative ﬂuctuations were seen in other helical regions of dDAT,
which agreed well with HDX-MS data on LeuT (EL2, IL3, and
TM7) reﬂecting on local similarities in the structural plasticity
between the two. Like for LeuT, the ligand-dependent appearance
and rate of opening during cooperative ﬂuctuations suggest that
these regions serve a role in the transport mechanism. The ligand-
dependent correlated exchange seen for peptides covering TM12
and the C-helix mark a possible role for these regions in the
transport mechanism or regulation of transporter activity. Recent
studies of LeuT combining native MS and molecular dynamics
simulations59 have suggested a possible dimerization interface
formed by lipid-mediated interaction between the intracellular
part of TM9 and TM12. In contrast, studies on hDAT suggested
that TM12 is not involved in dimer formation, possibly because
of the kink in TM1260. The concomitant observation of EX1
kinetics in the C-helix support suggestions from hDAT of its
involvement in activity-mediated regulation6,61. Slow cooperative
ﬂuctuations, or EX1 kinetics, are rare observations in proteins,
but have also been observed in transporters such as P-
glycoprotein48, G-protein coupled receptors49, and in
enzymes62. EX1 behavior arises from correlated protein motions
that occur slowly relative to the rate of the chemical exchange
reaction. Our observation of EX1 in several TM helical regions of
DAT is in good correlation with our earlier observations from
LeuT27 and can be interpreted as the hydrogen bonds of the
helical segment breaking in a slow concerted manner, i.e., a
partial unwinding or bending of the helical structure. This par-
tially unwound helix stays open or unwound in a sufﬁcient time-
frame to allow several amides to exchange their hydrogens in a
correlated manner (i.e., kcl » kch) before closing again. Interest-
ingly, the observation that the EX1 kinetics was attenuated by
ligand binding could suggest that partial helix unwinding in the
observed domains is an integrated part of the translocation
mechanism. Another possibility is that it could be a result of local
irreversible destabilization, especially because the most pro-
nounced EX1 is observed in the apo state, which is the most
unstable state. Indeed, our SEC shows that monomeric dDAT in
the apo state is slowly converted into multimers and as a result,
the monomeric fraction falls to ~66% after 8 h. However, dDAT
in the Na+-bound state exhibits no multimerization or change in
stability even after 8 h, yet we still see pronounced EX1 kinetics in
both the Na+-bound and Na++DA-bound states. Furthermore,
for all domains exhibiting EX1 apart from TM12, the exchange to
the fully deuterated high-mass isotopic envelope happens much
faster (t1/2 < 15 min) than the partial formation of multimers
observed exclusively for the apo state. Overall, this suggests that
there is no correlation between the slow destabilization of the
dDAT apo state and the EX1 kinetics observed across all DAT
states. Notably, our apo state included Cl−, which might obscure
the observation of a correct apo state as binding of Cl− to dDAT
might occur. Nevertheless, studies of DAT suggest a very low
afﬁnity for Cl− in the absence of Na+63.
Taken together, our HDX-MS data provide the ﬁrst direct
experimental evidence for spatially-resolved conformational
dynamics of DAT. The ﬁndings support established models of the
general alternating access transport mechanism based on studies
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of bacterial homologs. Moreover, our data reveal substrate-
induced conformational changes, which suggest key features for
understanding the transport mechanism, structural plasticity, and
regulation of eukaryotic NSSs. Comparison of our data with
published HDX-MS studies of LeuT highlights important region-
speciﬁc differences in dynamics between bacterial homologs and
the eukaryotic transporters. Our work provides a comprehensive
framework for future detailed studies into the transition path
between transport states to fully elucidate the mechanism and
regulation of clinically relevant NSSs.
Methods
Modeling and MD simulations. A model of dDAT was constructed using the
crystal structure of dDAT in complex with Na+, Cl−, and DA (PDB ID: 4XP1). In
the crystal structure, the segment from Ser162 to Val202 is truncated for crystal-
lization reasons, and was modeled using MODELLER9.1864. Similarly, mutations
that had been introduced in the crystal structure were also reverted to the wild-type
sequence. The two Na+ ions, the Cl− ion, the DA molecule in the binding site were
kept during model building together with the cholesterol molecule (CHOL) and the
water molecules found in the crystal structure. Furthermore, the cholesterol ana-
logue (cholesteryl hemisuccinate) found at the interface between TM2 and TM7 in
the crystal structure (previously labelled32 as site 2) was replaced by a CHOL
molecule. The N-terminal (1–24) and C-terminal (601–645) regions, which are
missing in the crystal structure, were not included in the model to decrease
computational cost, and the termini were instead capped by an acetyl and amide
group, respectively. Finally, the model was aligned to the dDAT structure (PDB ID:
4M48) in the Orientation of Protein in Membranes database65. DA in the binding
site was modeled in its protonated state as suggested by Zeppelin et al.32. Force ﬁeld
parameters for the ligands were generated using the CHARMM General Force
Field (CGenFF)66 and the CHARMM-GUI web interface67. The CHARMM36m
force ﬁeld68 was used for the protein.
To model dDAT in a mixed bilayer, the above model of dDAT was embedded
into a ﬂat, mixed lipid bilayer consisting of POPC/POPE/POPG/CHOL (3:1:1:1;
with a total of 606 molecules) and solvated in a box of TIP3P water containing Na+
and Cl− ions at 0.2 M. After equilibration, the size of the box was 13.7 nm, 13.7 nm
and 12.2 nm in the x, y, and z dimension, respectively. To mimic dDAT in a
detergent micelle, the CHARMM-GUI web interface67 was used to embed the
model into a micelle consisting of 120 n-dodecyl β-D-maltoside (DDM) molecules
and solvated in a cubic box of TIP3P water molecules with a size of 11.8 nm in each
dimension. The CHARMM36 lipid force ﬁeld69 was used for all lipid molecules.
In the MD simulations the temperature was kept constant at 300 K using a Nose-
Hoover thermostat with a 1 ps coupling constant, and the pressure at 1.0 bar using the
Parrinello-Rahman barostat with a 5 ps time coupling constant. A cutoff of 1.2 nm
was applied for the van der Waals interactions using a switch function starting at
1.0 nm. The cutoff for the short-range electrostatic interactions was also at 1.2 nm and
the long-range electrostatic interactions were calculated by means of the particle mesh
Ewald decomposition algorithm with a 0.12 nm mesh spacing. All MD simulations
were performed using Gromacs201870. One 500 ns and four 100 ns simulations were
performed for each system of dDAT in the lipid bilayer and the micelle.
Construct. Full-length dDAT with a C-terminal thrombin site (LVPRGS)
followed by an 8 histidine-tag and ﬂanking unique restriction sites
(BssHII–MluI–EcoRI–ApaI–dDAT–AgeI–SalI–NotI–XbaI) was synthesized by
GenScript Inc. (Piscataway, NJ) and cloned into the pEG BacMam expression
vector35 using BssHII and XbaI by GenScript Inc. (Piscataway, NJ).
Expression and puriﬁcation. The wild-type dDAT was expressed by transduction
of mammalian Expi293F cells (Gibco) grown in suspension with baculovirus
produced in Sf9 cells (Expression Systems). Cells were harvested by centrifugation
and membranes were prepared in 20 mM Tris, pH 8.0, 150 mM NaCl, 30% gly-
cerol, 10 µg ml−1 benzamidine and 10 µg ml−1 leupeptin by dounce homogeniza-
tion followed by sonication. Unlysed cells and cell debris were removed by
centrifugation at 750 × g and membranes were then pelleted at 125,000 × g for 3 h.
Membranes were further solubilized in buffer containing 40 mM Tris, pH 8.0,
150 mM NaCl, 20 mM n-dodecyl β-D-maltoside (DDM), 4 mM cholesteryl
hemisuccinate (CHS), 5 µg ml−1 benzamidine and 10 µg ml−1 leupeptin for 1.5 h
by gentle end over end mixing followed by centrifugation at 55,000 × g for 30 min.
The clariﬁed supernatant was batch incubated with His-Pur Ni-NTA resin
(Thermo Fisher Scientiﬁc) and 25 mM imidazole for 2 h at 4 °C under gentle end
over end mixing. The resin was washed in buffer A (40 mM Tris, pH 8.0, 5%
glycerol, 14 µM lipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocoline (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), and 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (POPG) at a weight ratio of
3:1:1), 1 mM DDM, 0.2 mM CHS) containing 300 mM NaCl, 5 µg ml−1 benza-
midine and 10 µg ml-1 leupeptin with a stepwise gradient of 6 column volumes of
buffer supplemented with 30 mM imidazole followed by 6 column volumes of 60
mM imidazole buffer, and the protein was then eluted with 300 mM imidazole
buffer. Fractions containing dDAT was pooled and stored at −80 °C until further
use. Buffers and protein samples were kept on ice or at 4 °C at all times during the
puriﬁcation. Puriﬁed dDAT for analytical size-exclusion chromatography and
HDX-MS experiments was thawed and dialyzed two times for 2 h followed by one
time overnight at 4 °C against buffer A containing 200 mM of either NaCl or CsCl
using 0.5 ml Slide-A-Lyzer MINI dialysis devices (10 kDa MWCO, Thermo Fisher
Scientiﬁc).
SDS-PAGE. The purity and concentration of puriﬁed dDAT were analyzed by
SDS-PAGE. Deglycosylated dDAT was prepared by incubation with PNGaseF
(Sigma–Aldrich) overnight at 25 °C. Samples were mixed with 4X Laemmli sample
buffer containing 167 mM DTT and separated on Any kD Mini-PROTEAN TGX
Precast gels (BioRad). Gels were stained by GelCode Blue Stain reagent (Thermo
Fisher Scientiﬁc) according to the protocol provided by the manufacturer. Bovine-
serum albumin (Sigma–Aldrich) standards were used for quantiﬁcation of dDAT.
Gels were analyzed and quantiﬁed using the GelAnalyzer 2010 software.
Ligand binding assay. The activity of puriﬁed dDAT was assessed by scintillation
proximity assay (SPA). 50 ng per well (7 nM) of protein was incubated with
1.25 mgml−1 copper yttrium silicate (Cu-YSi) beads (PerkinElmer) in buffer A
supplemented with 200 mM NaCl. Nisoxetine saturation binding was set up using
10% [3H]nisoxetine (79.8 Ci mmol−1; PerkinElmer). DA competition binding
assays was performed with 30 nM [3H]nisoxetine and increasing concentration of
unlabeled DA. Non-speciﬁc binding was determined in the presence of 100 µM
unlabelled nortriptyline. SPA experiments were set up in triplicate wells of a 96-
well white wall clear bottom plate. The samples were incubated for 30 min at room
temperature. The samples were further incubated for 16 h incubation at 4 °C for
nisoxetine saturation binding experiments. [3H]nisoxetine binding was monitored
using a MicroBeta liquid scintillation plate counter (PerkinElmer) using a 1-min
counting protocol. Data were analyzed by non-linear regression analysis and ﬁtted
to a one-site saturation or dose-response function, respectively, using GraphPad
Prism 7 software (GraphPad, San Diego, CA).
Analytical size-exclusion chromatography. dDAT samples were incubated at 25
°C in buffer A containing either 200 mM NaCl or CsCl. After various time intervals
(0, 1, 4, and 8 h) the samples were subjected to size-exclusion chromatography on a
Superose 6 Increase 10/300 GL column (GE Healthcare) pre-equilibrated with the
corresponding buffer A with 200 mM NaCl or CsCl.
Hydrogen-deuterium exchange. Prior to HDX, dDAT was incubated at 25 °C for
30 min at a concentration of 1.5 µM in buffer A containing 200 mM of either NaCl,
CsCl, or 200 mM NaCl and 400 µM DA. The exchange reaction was initiated by
diluting the dDAT samples 1:4 with 94% D2O buffer A supplemented with 200 mM
of either NaCl or CsCl at 25 °C resulting in 75.2% deuterium content during HDX
and 40 µM DA in the NaCl and DA condition. The labeling reaction was quenched
at various time points (15 s, 1 min, 10 min, 60 min, and 480 min) by mixing a
sample 1:1 with ice cold 220 mM phosphate buffer, pH 2.3, 2 M urea. Quenched
samples were immediately frozen and stored at −80 °C until further use. For
maximum-labeled control samples, dDAT was predigested using the same condi-
tions as for the HDX experiments. After online pepsin digestion, dDAT peptides
were desalted, eluted, and collected manually in a single fraction and lyophilized.
The dDAT peptides were then reconstituted in 75.2% deuterated buffer A con-
taining 200 mM NaCl and incubated for 24 h at 25 °C to reach full deuteration
before quenching the reaction. The HDX-MS data presented in this paper is the
average of at least three technical replicate measurements for each time point.
Liquid chromatography and mass spectrometry. Quenched samples (15 pmol)
were thawed and loaded onto a cooled (0 °C) nanoACQUITY UPLC system
(Waters) with HDX technology. Samples were ﬁrst subjected to proteolytic
digestion at 20 °C on an in-house packed pepsin column containing immobilized
pepsin agarose resin (Thermo Fisher scientiﬁc) followed by rapid desalting on a C8
trap column (VanGuard pre-column ACQUITY UPLC BEH C8 1.7 µm, Waters)
for 3 min at a ﬂow rate of 200 µl min−1 solvent A (0.23% formic acid in water, pH
2.5). The peptides were then separated by reversed-phase chromatography over a
C8 analytical column (ACQUITY UPLC BEH C8 1.7 µm, 100 mm, Waters) with a
C8 trap column in front using a linear gradient from 8–30% solvent B (0.23%
formic acid in acetonitrile) over 10 min at a ﬂow rate of 40 µl min−1. Subsequently,
peptides were analyzed on a hybrid Q-TOF SYNAPT G2-Si mass spectrometer
(Waters) with electrospray ionization in positive ion mode and lock-mass cor-
rection using Glu-ﬁbrinopeptide B. Ion mobility was used to further separate ions
in the gas-phase in order to enhance peak capacity and minimize spectral overlap.
The ion mobility cell was operated using a constant nitrogen ﬂow of 90 ml min−1
at a wave velocity of 580 m s−1 and a wave height of 40 V. The maximum-labeled
control samples were processed and analyzed using the HDX-MS workﬂow as
described above with the only exception that the pepsin column was removed to
avoid additional digestion. Non-deuterated samples were used for peptide identi-
ﬁcation by tandem mass spectrometry (CID) using a combination of data-
independent acquisition (DIA) and data-dependent acquisition (DDA) with the
ion mobility cell turned off.
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HDX-MS data evaluation and statistical analysis. Peptides were identiﬁed from
non-deuterated samples using ProteinLynx Global Server 3.0 (PLGS) (Waters).
Only peptide hits with a PLGS Ladder Score above 1.0 and with a mass error below
10 ppm for the precursor ion were accepted for peptides identiﬁed by DDA.
Peptides identiﬁed by DIA were ﬁltered using DynamX 3.0 (Waters) so that only
peptides with at least two fragmentation products, 0.2 fragment ions per amino
acid, and below 10 ppm mass error for the precursor ion were accepted. Fur-
thermore, peptides had to be identiﬁed in 50% of the DIA runs. The deuterium
uptake was determined for all identiﬁed peptides using DynamX 3.0 (Waters). All
peptide assignments were manually veriﬁed and noisy and overlapping spectral
data were discarded from the HDX analysis. Maximum-labeled control samples
were used to calculate the back-exchange (BE) for all individual peptides by the
equation
BE ð%Þ ¼ 1m75:2% m0%
mMAX m0%
 
 100% ð1Þ
where m75:2% is the mass of the maximum-labeled peptide, m0% is the mass of the
non-deuterated peptide, and mMAX is the theoretical maximum deuterium uptake
of the peptide (excluding N-terminus and prolines). The calculated back-exchange
was used to normalize the back-exchange between measuring days allowing
quantitative comparison of samples not measured on the same day. HX-Express 2.0
was used to further analyze peptides showing bimodal isotopic patterns upon
deuteration. The number of backbone amide hydrogens undergoing correlated
exchange (#NHs) was determined using the equation
#NHs ¼ ΔHDX  100%
100% BE ð2Þ
where ΔHDX is the difference in HDX between the low- and high-mass popula-
tion, which was calculated (n= 3) and corrected according to the measured back-
exchange (BE) of the respective peptide. For peptides displaying EX1 kinetics, the
relative abundance of the two isotopic envelopes were determined using HX-
Express 2.0, and the relative abundance of the low-mass population (n= 3) was
plotted against the labeling time. The data were then ﬁtted to an exponential decay
function
y ¼ ekop x ð3Þ
using GraphPad Prism 7 software (GraphPad, San Diego, CA) to extract the best-ﬁt
values for the kinetic parameters (i.e., kop and the half-life of the folded state).
Comparisons of states for all identiﬁed peptides were performed in Excels software
(Microsoft) using either a homoscedastic or a heteoscedastic Student’s t-test (α=
0.01) depending on a F-test (α= 0.05), which compared the variance of deuterium
uptake from two different states for each single peptide at a single time point.
Peptides were only considered to have a signiﬁcant difference in HDX between two
states if two consecutive time points showed a signiﬁcant difference in deuterium
incorporation (p < 0.01). A signiﬁcance threshold for all peptides used to deﬁne a
signiﬁcant difference in the difference charts was set to 0.26 Da, 0.20 Da, or 0.23 Da
for differences in HDX between the Cs+ and Na+ states, the Na+ and Na++DA
states, or Cs+ and Na++DA states, respectively, corresponding to the 95% con-
ﬁdence interval (CI) calculated according to
CI ¼ x ± t  σﬃﬃﬃ
n
p ð4Þ
Here, x is the average difference in deuterium content assuming a zero-centered
distribution (x= 0), t is 4.303 for the 95% CI with 2 degrees of freedom, σ is the
pooled propagated standard deviation of differences in deuterium content for all
peptides across all time points (i.e., 0.25–480 min) for the two states compared, and
n is the number of replicate samples (n= 3). HDX results were mapped onto the
dDAT crystal structure (PDB ID: 4XP1) using PyMOL.
To allow access to the HDX data of this study, the HDX Summary Table
(Supplementary Table 1) and the HDX Data Table (Supplementary Table 2) are
included in the Supplementary Information according to the community-based
recommendations71.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information ﬁle. The source data underlying Figs. 2, 3, 4, 5d, Table 1 and
Supplementary Figs. 1, 3, 4, 7 are provided as a Source Data ﬁle. Mass spectrometry data
ﬁles including the processed DynamX ﬁle and an overview of the HDX-MS data
(Supplementary Tables 1 and 2) have been deposited to the PRoteomics IDEntiﬁcation
(PRIDE) Database with the dataset identiﬁer PXD013841.
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